2 cme credits
granted by the SSMO and SSH
Management of Multiple Myeloma Patients During the COVID-19 Pandemic
Length: 120 minutes
It should take approximately 2 hours to complete this module.
This module will combine two sections: a webinar-based section, which will include an expert panel discussion and a text-based section that will provide a comprehensive overview of the latest knowledge, experience, and available information regarding the risks and management of multiple myeloma patients during the COVID-19 outbreak as well as multiple myeloma patients infected with SARS-CoV-2.
This module will:
- Present the latest clinical experiences and case reports from renowned experts on COVID-19 and multiple myeloma in a webinar-based panel discussion
- Provide essential up-to-date data on the epidemiology, pathophysiology, and potential treatments for COVID-19
- Introduce the prevalence of COVID-19 among patients with multiple myeloma and discuss the risks for unfavorable outcomes
- Discuss available recommendations and guidelines for the management of multiple myeloma patients during the COVID-19 pandemic